SCHEDULE 13D

Company

Sofgen Pharma S.A.

Filed

October 12, 2021

Accession Number

0001213900-21-052386

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →